Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2216739 Target Snapshot

Carnitine O-palmitoyltransferase 1, muscle isoform · SINGLE PROTEIN · Homo sapiens

492Compounds
7Assays
0Approved Drugs
502.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q92523. Use UniProt Q92523 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q92523 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Carnitine O-palmitoyltransferase 1, muscle isoform as ChEMBL target CHEMBL2216739, mapped to UniProt Q92523. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Carnitine O-palmitoyltransferase 1, muscle isoform
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2216739
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q92523
Carnitine O-palmitoyltransferase 1, muscle isoform
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Carnitine O-palmitoyltransferase 1, muscle isoform is the right protein anchor across sources, using UniProt Q92523 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCarnitine O-palmitoyltransferase 1, muscle isoform
UniProt AccessionQ92523
Component TypeProtein
Sequence Length772 aa

Carnitine O-palmitoyltransferase 1, muscle isoform

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Carnitine O-palmitoyltransferase 1, muscle isoform, mapped to UniProt Q92523. Sequence length is 772 aa.

Mapped IDQ92523
Review nameCarnitine O-palmitoyltransferase 1, muscle isoform
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC50502.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2216778 7.8 IC50 16.0 Preclinical
CHEMBL2216779 7.68 IC50 21.0 Preclinical
CHEMBL3431544 6.87 IC50 133.95 Preclinical
CHEMBL3431722 6.84 IC50 145.3 Preclinical
CHEMBL2216771 6.8 IC50 160.0 Preclinical
CHEMBL3431461 6.7 IC50 202.0 Preclinical
CHEMBL3431514 6.65 IC50 226.05 Preclinical
CHEMBL3431634 6.63 IC50 235.3 Preclinical
CHEMBL3431771 6.59 IC50 259.2 Preclinical
CHEMBL2216769 6.44 IC50 360.0 Preclinical
Distribution

pChEMBL Value Distribution

57
5.0
64
5.5
43
6.0
7
6.5
0
7.0
2
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

7
Total Assays
251
Tested Compounds
1
Assay Types
Binding — 7 assays, 251 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 5 247 5.3
cell-based format 1 3 6.8
mitochondrion format 1 1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine